CA-125 Levels During Pregnancy: What You Need to Know - Family Medicine

More Info

---

Understanding CA-125 Levels During Pregnancy: What You Need to Know
CA-125, or cancer antigen 125, is a protein that is often elevated in the presence of certain types of cancers, particularly ovarian cancer. However, it is important to note that CA-125 is not exclusively a cancer marker; its levels can also be influenced by various benign conditions and physiological states, including pregnancy.
In your case, you are 30 years old and have been diagnosed with a 4 cm tumor on your left ovary during your pregnancy. Your CA-125 level has risen to 143, which is significantly higher than the normal range (typically below 35 U/mL). While elevated CA-125 levels can be concerning, especially in the context of an ovarian tumor, it is crucial to interpret these results within the broader context of your health and pregnancy.

Firstly, pregnancy itself can lead to elevated CA-125 levels. Studies have shown that CA-125 levels can increase during pregnancy due to the physiological changes that occur in the body. The placenta produces CA-125, and levels can be particularly high in the first trimester. Therefore, while your elevated CA-125 level is concerning, it does not automatically indicate the presence of a malignant tumor.
The characteristics of the tumor you described—being regular in shape and clear—are also important factors to consider. Generally, benign ovarian tumors, such as functional cysts or dermoid cysts, can present with these features. However, the only definitive way to determine the nature of the tumor (benign vs. malignant) is through further diagnostic evaluation.

Regarding your concerns about continuing the pregnancy and the potential for tumor progression, it is essential to have a thorough discussion with your healthcare provider. If you wish to maintain the pregnancy, there are options for monitoring the situation closely. This may include regular ultrasounds to assess the tumor's size and characteristics, as well as repeat CA-125 testing to monitor any changes in levels over time.

If there is a need for further investigation, such as imaging studies or a biopsy, your healthcare provider will consider the risks and benefits of these procedures in the context of your pregnancy. In some cases, if the tumor is suspected to be malignant or if there are concerning features, a referral to a specialist in maternal-fetal medicine or gynecologic oncology may be warranted. They can provide a more comprehensive evaluation and discuss potential interventions that can be safely performed during pregnancy.

In summary, while an elevated CA-125 level can be alarming, it is not definitive for malignancy, especially in the context of pregnancy. The best course of action is to maintain open communication with your healthcare team, who can guide you through the necessary monitoring and any potential interventions while prioritizing both your health and the health of your baby. Regular follow-ups and imaging studies will help ensure that any changes in your condition are promptly addressed.